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Mutations in codon 12, 13 or 61 of the ras genes, H-ras,
K-ras and N-ras, convert these genes into active oncogenes
(Barbacid, 1987). ras Gene mutations can be found in a
variety of tumour types, although the incidence varies greatly
(Bos, 1989). In animals, a wide range of xenobiotic agents
are capable of inducing mutations in the ras oncogene family
(Barbacid, 1987). Little is known about the involvement of
mutagenic agents in the induction of ras mutations in
humans. In cutaneous melanomas mutations of the N-ras
gene (codon 13 and 61) were found in seven out of 37 tested
cases (Van't Veer et al., 1989). The primary tumours of these
7 patients were exclusively located on continuously sun-
exposed body sites. These mutations were all near dipyrimi-
dine sites, suggesting an active role for ultraviolet (UV)
radiation in the induction of the mutations. Shukla et al.
(1989) found in one out of 22 tested primary cutaneous
melanomas N-ras mutation in codon 61, but no details of
sun exposure were available. Melanoma of the uvea (iris,
ciliary body and choroid) is the most common primary intra-
ocular malignancy in adults (Cutler & Young, 1975). The
incidence of uveal melanoma in whites is eight times the
incidence in blacks and threefold greater than in certain
Asian groups (Hakulinen et al., 1987). In the Caucasian
population individuals with light irides have three times the
risk ofdeveloping uveal melanoma compared to persons with
brown eyes (Gallagher et al., 1985). Early life exposures to
sunlight have been found to be especially important in the
development of intra-ocular melanoma. (Tucker et al., 1985).
Recent epidemiological studies have reported an elevated risk
for Northern European ancestry, light skin colour, the pre-
sence of 10 or more cutaneous naevi, use of sunlamps a-nd
intense sun exposure (Seddon et al., 1990). Holly et al. (1990)
found an increased risk of developing uveal melanoma for
the apparent effects of UV exposure (severe eye burn, snow
blindness), and for host factors, like light eye colour and a
propensity to burn rather than tan. These findings implicate
sunlight as an environmental risk factor for this disease. The
colour of the iris is determined by the degree of pigmenta-
tion; limited pigmentation leads to a blue or grey iris and
high concentrations of melanin are present in brown irides.
Melanin can absorb UV as well as visible light.
To investigate possible UV mediated activation of N-ras
genes we analysed 29 uveal melanomas for mutations. Table
I summarises the patient data. The location of the intra-
ocular tumours is illustrated in Figure 1. When frozen tissue
sections were examined it appeared that 17 samples con-
tained 100%, 8>90%, 3>75% and 1 50% tumour tissue.
DNA was extracted from five sections of 5 gm thickness of
Table I Patient characteristics
Clinical characteristics No. ofpatients
Sex
male 17
female 12
Histology
Spindle cell type 12
Mixed cell type 8
Epithelioid cell type 9
TNM classification*
Ti 2
T2 8
T3 15
T4 4
Pigmentation of the iris
minimal 18
moderate 6
heavy 2
unknown 3
*TNM classification ofophthalmic tumours. UICC Geneva 1985.
iris: 1
ciI. body: 6
chor.eq.:3
chor. post.: 18
chor.dif.: 1
retina
sclera
Figure 1 Location of the intra-ocular tumours. White area: iris.
Stipled area: ciliary body. Striated area: equatorial choroid. Black
area: posterior choroid. Diffuse (dif.) in the choroid: one melan-
oma.
each tumour, adjacent to the one used for histopathology.
The extracted DNA was used as a template in the poly-
merase chain reaction (PCR) following the protocol as
supplied by the manufacturer of Taq polymerase (Cetus,
USA). The primers used for the amplification of the fragment
comprising codons 12 and 13 were sense primer 5' CTGAG-
TACAAACTGGTGGTTGGT 3', antisense primer 5' CAA-
AGTGGTTCTGGATTAAGCT 3' and for amplification of
codon 61: sense primer 5' AGTGGTTATAGACGGTGAA-
AC 3', antisense primer 5' GTGCTCATGTATTGGTCTCT-
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Figure 2 Example of autoradiograph from sequence gel. In the left panel the sequence of the amplified DNA from melanomas 5
and 9 is shown for the area surrounding codons 12 and 13. Note the sequence shown is that of the antisense strand. In the right
panel the sequence reactions were performed on amplified DNA from the area surrounding codon 61 in melanoma 5 and 9
respectively (antisense strand).
CAT 3'. The amplified fragments were separated from the
primers on a low melting point agarose gel, eluted from the
gel and subjected to an asymmetric amplification using a
200-fold lower concentration of the antisense primer (Gyl-
lenstein, 1989). This results in preferential synthesis of the
sense strands. The single strand was subsequently isolated
from an agarose gel and used as a template in sequencing
reactions using the antisense primers and Sequenase (Prow
mega). The reactions were performed as suggested by the
supplier of the enzyme, with a 4 fold higher concentration of
dideoxynucleotides and an elongation step of 1 min. A plas-
mid with a mutation in codon 13 (GGT-GTT) served as a
positive control, whereas normal DNA tissue served as a
negative control.
Examples of autoradiographs from sequencing gels are
depicted in Figure 2. No deviations from the wild type
sequence were found in codons 12 and 13 in these samples,
nor in the other 27 melanomas. Similarly, in none of the 29
melanoma samples mutations in codon 61 could be observed.
It is clear from our study, that uveal melanomas differ from
the cutaneous melanomas with regard to the N-ras mutation
rate: N-ras mutations do not seem to play an important role
in developing uveal melanoma. It is possible, however, that
the other two ras genes may contain mutations. Shukla et al.
(1989) described K-ras mutations in three out of 22 patients
with primary cutaneous melanomas. In this latter study no
correlation was found between ras mutations and UV ex-
posure. The patients described here, were all Caucasians livesd
in the Netherlands and possessed mainly light irides. This is
consistent with some of the risk factors mentioned for
developing uveal melanoma.
The cornea effectively filters out all UV radiation shorter
than 295 nm. In children a substantial transmission of UV-A
(320-400 nm) and UV-B (290-320 nm) occurs, which de-
creases with age (Lerman, 1980). Short UV wavelengths (UV-
B) cause the formation of pyrimidine dimers in the DNA
(Kraemer et al., 1984). It is believed that the choroid and
ciliary body are protected from UV exposure and also from a
large portion of the more energetic wavelengths of the visible
spectrum by the overlying retina and retinal pigment epithe-
lium (Lerman, 1986). Thus we must conclude that although
there is ample epidemiological evidence for a role of UV
radiation as a risk factor in developing uveal melanoma, it is
questionable if UV radiation is able to reach the choroid and
ciliary body. In the contrary the iridic surface is not pro-
tected by the lens or by overlying tissue from UV A and B
radiation. The well documented tendency for iris melanoma
to occur in the inferior sector of the iris (Jacobiec et al.,
1981), where exposure to sunlight is presumably the greatest,
supports the view that the origin ofthese tumours is environ-
mentally related. However, the incidence of iris melanoma is
much smaller compared to those arising in the ciliary body
or choroid. Another argument against the direct role of UV
radiation in uveal melanoma might be that incidence and
mortality rates for uveal melanoma are changing very little in
Europe, North America, Japan and Australia (Strickland &
Lee, 1981). This finding is in contrast to the rapid increas-
ment of the incidence of cutaneous melanoma.
Hersey et al. (1983) found an increase in T suppressor cells
after solarium exposure and a relative decrease in T helper
cells. Sunlight may work indirectly by inducing a systemic
alteration in immunologic function (Stem, 1984). Although
the role of these findings to human disease is not established,
immunologic pertubations caused by exposure to sunlight
may play a role in developing uveal melanoma, as part of
multifactorial disease.NO N-RAS MUTATIONS IN HUMAN UVEAL MELANOMA 413
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